While Burger King hasn't officially confirmed it, customers in New York are beginning to notice that salads are among the items missing from its menu.
Social media users and several Burger King restaurant managers said that the fast-food chain had stopped offering salads. Several Burger King locations in Queens and Long Island have already removed salads, of any variety, from their menu boards.
As of January, a Chicken Garden Salad and a side salad were available.
Four New York-area restaurant managers confirmed that salads were "gone" and "won't be coming back," with one of them quipping that water is the healthiest thing on their menu.
Carrols Restaurant Group, which operates more than 1,000 restaurants and is the largest Burger King franchisee in the US, announced recently that it is reducing the number of chicken nuggets in its meals from 10 pieces to 8 pieces, without offering consumers a lower price.
Carrols explained that the move was in response to inflation and an alternative to raising prices.
The Whopper will be phased out from the chain's main discount menu, as well as from Two for $5 and Two for $6 specials.
According to RBI's CEO José Cil, the Whopper had been on the bargain menu "for far too long."
Burger King announced it would market the Whopper as a premium, "iconic" offering in the future.
Burger King may possibly eliminate single, double, and triple Whoppers as separate items and make changes to the original chicken sandwich with the new Ch'King sandwich becoming the chain's standard offering.


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
U.S. Stock Futures Slip as Markets Brace for Big Tech Earnings and Key Data
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Taiwan Urges Stronger Trade Ties With Fellow Democracies, Rejects Economic Dependence on China
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
India Budget 2025 Highlights Manufacturing Push but Falls Short of Market Expectations
JPMorgan Lifts Gold Price Forecast to $6,300 by End-2026 on Strong Central Bank and Investor Demand
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Dollar Holds Firm as Strong U.S. Data, Fed Expectations and Global Central Bank Moves Shape Markets
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 



